Novo Nordisk

novonordisk.es

Novo Nordisk Pharma S.A.

Via de los Poblados, 3, Parque Empresarial Cristalia Edificio 6-3a Planta
28033 Madrid
Spain

Phone

novonordisk.es
Contact
Profile News

About Novo Nordisk

Novo Nordisk is a global health care company and more than 90 years of innovation and leadership in diabetes. The company also holds leadership positions in the care of hemophilia and growth disorders.

Read more about Novo Nordisk

Advertisement

Revolutionize your production: real-time Raman analysis for maximum efficiency
Revolutionize your production: real-time Raman analysis for maximum efficiency
Efficient inline analysis for liquids and solids
Efficient inline analysis for liquids and solids
User-friendly software for effortless Design of Experiments (DoE)
User-friendly software for effortless Design of Experiments (DoE)

News about Novo Nordisk

Novo Nordisk

30-Apr-2024 | science

Breakthrough in research on brown fat

Hope for strategies that support weight loss: Researchers from Denmark and Germany have found brown fat’s “off-switch"

Read news
Novo Nordisk

26-Mar-2024 | business & finance

Possible billion-euro deal: Novo Nordisk wants to acquire MHH spin-off

Cardior Pharmaceuticals is developing a drug for the treatment of heart failure. The Danish pharmaceutical group Novo Nordisk is planning to acquire the ...

Read news
Novo Nordisk

19-Aug-2020 | research and development

Evotec and Novo Nordisk form alliance to develop novel therapies for kidney diseases

Milestone potential of more than € 150 m per product

Read news
Novo Nordisk

23-Aug-2018 | business & finance

Evotec and Novo Nordisk form research alliance in diabetes and obesity

Evotec AG announced a strategic alliance with Novo Nordisk to discover and develop novel small molecule therapies to treat patients suffering from diabetes ...

Read news
Novo Nordisk

20-Aug-2018 | business & finance

Novo Nordisk acquires Bristol based biopharmaceutical start-up

Ziylo and Novo Nordisk A/S today announced that Novo Nordisk has acquired all of the shares of Ziylo, a University of Bristol spin-out company based at ...

Read news
Novo Nordisk

13-Oct-2010 | business & finance

Novo Nordisk completes divestment of ZymoGenetics, Inc.

Bristol-Myers Squibb Company and ZymoGenetics, Inc. have signed a definitive agreement providing for the acquisition of ZymoGenetics by Bristol-Myers ...

Read news
Novo Nordisk

10-Sep-2010 | business & finance

Novo Nordisk divests its ownership of ZymoGenetics, Inc.

Bristol-Myers Squibb Company and ZymoGenetics, Inc. have announced the signing of a definitive agreement providing for the acquisition of ZymoGenetics by ...

Read news
Novo Nordisk

13-Jan-2010 | manufacturing

Gerresheimer Sets up New Production Facility for Insulin Pen Systems in Brazil

Expansion of Cooperation With Diabetes Leader Novo Nordisk

Read news
Show more news about Novo Nordisk

Here you will find Novo Nordisk Pharma S.A.

Last viewed contents

Water-shy proteins weaken protection against cancer - Special mutations in important protective proteins lead to the proteins being broken down longer and therefore faster

Water-shy proteins weaken protection against cancer - Special mutations in important protective proteins lead to the proteins being broken down longer and therefore faster

Go to page